David P. Snow
Keine laufenden Positionen mehr
Profil
David P.
Snow formerly worked at Bristol-Myers Squibb Pharmaceutical Research Institute, as Senior Director, Radius Health, Inc., as Chief Commercial Officer from 2015 to 2017, AstraZeneca LP, as Vice President-Prescription Medication from 2010 to 2011, AstraZeneca Pharmaceuticals Co., Ltd., as President from 2012 to 2014, and Eloxx Pharmaceuticals, Inc., as Chief Business Officer from 2018 to 2020.
Mr. Snow received his undergraduate degree from Auburn University and Masters Business Admin degree from The Leonard N Stern School of Business.
Ehemalige bekannte Positionen von David P. Snow
| Unternehmen | Position | Ende |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29.02.2020 |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 15.12.2017 |
AstraZeneca Pharmaceuticals Co., Ltd.
 AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The company believes in the power of science and considers it a top priority in all of its work. | Präsident | 01.12.2014 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | 01.12.2011 |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | - |
Ausbildung von David P. Snow
| Auburn University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
| Bristol-Myers Squibb Pharmaceutical Research Institute | |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
AstraZeneca Pharmaceuticals Co., Ltd.
AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The company believes in the power of science and considers it a top priority in all of its work. | Health Technology |
